PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) Return-on-Tangible-Equity: 0.00% (As of . 20)


What is PT Brigit Biofarmaka Teknologi Tbk Return-on-Tangible-Equity?

PT Brigit Biofarmaka Teknologi Tbk ISX:OBAT Return-on-Tangible-Equity is 0.00% as of . 20. The stock has 1 warning sign investors should review. Among 1,873 Consumer Packaged Goods companies, PT Brigit Biofarmaka Teknologi Tbk ranks worse than 53390.23% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. PT Brigit Biofarmaka Teknologi Tbk's annualized net income for the quarter that ended in . 20 was Rp Mil. PT Brigit Biofarmaka Teknologi Tbk's average shareholder tangible equity for the quarter that ended in . 20 was Rp Mil. Therefore, PT Brigit Biofarmaka Teknologi Tbk's annualized Return-on-Tangible-Equity for the quarter that ended in . 20 was %.

The historical rank and industry rank for PT Brigit Biofarmaka Teknologi Tbk's Return-on-Tangible-Equity or its related term are showing as below:

ISX:OBAT's Return-on-Tangible-Equity is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 7.72
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

PT Brigit Biofarmaka Teknologi Tbk  (ISX:OBAT) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.

Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.

PT Brigit Biofarmaka Teknologi Tbk Return-on-Tangible-Equity Related Terms

PT Brigit Biofarmaka Teknologi Tbk Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for PT Brigit Biofarmaka Teknologi Tbk's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Brigit Biofarmaka Teknologi Tbk Return-on-Tangible-Equity Chart

PT Brigit Biofarmaka Teknologi Tbk Annual Data
Trend
Return-on-Tangible-Equity

PT Brigit Biofarmaka Teknologi Tbk Semi-Annual Data
Return-on-Tangible-Equity

ISX:OBAT vs KHC, GIS: Return-on-Tangible-Equity Comparison

For the Packaged Foods subindustry, PT Brigit Biofarmaka Teknologi Tbk's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Brigit Biofarmaka Teknologi Tbk Return-on-Tangible-Equity vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, PT Brigit Biofarmaka Teknologi Tbk's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where PT Brigit Biofarmaka Teknologi Tbk's Return-on-Tangible-Equity falls into.


PT Brigit Biofarmaka Teknologi Tbk Return-on-Tangible-Equity Calculation

PT Brigit Biofarmaka Teknologi Tbk's annualized Return-on-Tangible-Equity for the fiscal year that ended in . 20 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( (+ )/ )
=/
= %

PT Brigit Biofarmaka Teknologi Tbk's annualized Return-on-Tangible-Equity for the quarter that ended in . 20 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (. 20) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a Return-on-Tangible-Equity of 0.00% as of . 20. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. According to the industry distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1873 companies in the Consumer Packaged Goods industry.
Is PT Brigit Biofarmaka Teknologi Tbk's Return-on-Tangible-Equity too high?
PT Brigit Biofarmaka Teknologi Tbk's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1873 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PT Brigit Biofarmaka Teknologi Tbk's Return-on-Tangible-Equity compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1873 companies for Return-on-Tangible-Equity. This places PT Brigit Biofarmaka Teknologi Tbk in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.72, based on 1,873 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Brigit Biofarmaka Teknologi Tbk's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Brigit Biofarmaka Teknologi Tbk stock overvalued right now?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT), the current Return-on-Tangible-Equity is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Brigit Biofarmaka Teknologi Tbk Business Description

Address Jalan Raya Tawangsari-Klaten, Rejosari, RT 01, RW 07, Kateguhan, Tawangsari, Kab. Sukoharjo, Jawa Tengah, IDN, 57561
PT Brigit Biofarmaka Teknologi Tbk is engaged in the herbal, cosmetic, and functional and botanical beverage manufacturing industry. The herbal products are used for traditional medicine products, including herbal capsules and honey, while the cosmetic products are various products for decorative and skin care. The functional and botanical beverage products are used for powdered drinks and tea.